Mutations of the FLT3 gene are found in approximately 30% of newly diagnosed adult AML cases (25% as ITDs and 10% as point mutations in the tyrosine kinase domain [TKD]) [38]. This evidence concerns the gene FLT3 and acute myeloid leukemia.